No harm, no foul

'No harm, no foul'

Using the law to forward business strategies is a common occurrence if not a matter of principle, so few will be surprised to note that Transkaryotic Therapies Inc. (TKTX) and partner Hoechst Marion Roussel Inc. have counter-punched

Read the full 417 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE